Patents by Inventor Phu Le

Phu Le has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12350042
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: July 8, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le, Christopher A. Thomas, Geoffrey V. McGarraugh, Gary Alan Hayter
  • Publication number: 20250194964
    Abstract: The present invention relates generally to systems, devices, and methods for in vivo monitoring of an analyte level. In particular, the present invention relates to sensors having saccharides or similar molecules present in glucose-oxidase containing sensing layers to improve sensor stability.
    Type: Application
    Filed: December 19, 2024
    Publication date: June 19, 2025
    Inventors: Phu Le, John LaTour, Soya Gamsey, Mark Yahnke, Albert Gutes-Regidor, Balasubrahmanya S. Bommakanti, Emmanuel Perez, Udo Hoss
  • Publication number: 20240415419
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: May 24, 2024
    Publication date: December 19, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20240407675
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Application
    Filed: June 3, 2024
    Publication date: December 12, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo HOSS, Phu LE, Yi WANG, Frank David FUJIMOTO, Suyue QIAN, Lam TRAN
  • Patent number: 12042275
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes an array two or more discontiguous sensing elements deposited on a substrate surface, where the sensing elements comprise one or more droplets of a sensing element formulation.
    Type: Grant
    Filed: April 14, 2021
    Date of Patent: July 23, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Patent number: 12029554
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: July 9, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Publication number: 20230397849
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 14, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230389830
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 7, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230389831
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 7, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230365758
    Abstract: Membranes permeable to an analyte may overlay the active sensing region of a sensor to limit the analyte flux and improve the response linearity of the sensor. Temperature variation of the analyte permeability can be problematic in some instances. Polymeric membrane compositions having limited variation in analyte permeability as a function of temperature may comprise: a polymer backbone comprising one or more side chains that comprise a heterocycle; and an amine-free polyether arm appended, via an alkyl spacer or a hydroxy-functionalized alkyl spacer, to the heterocycle of at least a portion of the one or more side chains.
    Type: Application
    Filed: April 21, 2023
    Publication date: November 16, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Balasubrahmanya S. BOMMAKANTI, John V. LATOUR, Udo HOSS, Tianmei OUYANG, Phu LE, Gary SANDHU, Kevin WALLIS
  • Patent number: 11667758
    Abstract: Membranes permeable to an analyte may overlay the active sensing region of a sensor to limit the analyte flux and improve the response linearity of the sensor. Temperature variation of the analyte permeability can be problematic in some instances. Polymeric membrane compositions having limited variation in analyte permeability as a function of temperature may comprise: a polymer backbone comprising one or more side chains that comprise a heterocycle; and an amine-free polyether arm appended, via an alkyl spacer or a hydroxy-functionalized alkyl spacer, to the heterocycle of at least a portion of the one or more side chains.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: June 6, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Balasubrahmanya S. Bommakanti, John V. Latour, Udo Hoss, Tianmei Ouyang, Phu Le, Gary Sandhu, Kevin Wallis
  • Publication number: 20230165489
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Application
    Filed: August 26, 2022
    Publication date: June 1, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo HOSS, Phu LE, Yi WANG, Frank David FUJIMOTO, Suyue QIAN, Lam TRAN
  • Patent number: 11457840
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes two or more sensing elements disposed laterally to each other, where the sensing surface is on a working electrode of in vivo and/or in vitro analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: October 4, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Publication number: 20220202326
    Abstract: The present disclosure provides redox mediators having two tridentate ligands and analyte sensors comprising such redox mediators. The present disclosure further provides methods of using such analyte sensors for detecting one or more analytes present in a biological sample of a subject.
    Type: Application
    Filed: January 3, 2022
    Publication date: June 30, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: John V. LaTour, Kevin P. Wallis, Phu Le, Udo Hoss
  • Publication number: 20220175282
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 9, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20220002498
    Abstract: Membranes permeable to an analyte may overlay the active sensing region of a sensor to limit the analyte flux and improve the response linearity of the sensor. Temperature variation of the analyte permeability can be problematic in some instances. Polymeric membrane compositions having limited variation in analyte permeability as a function of temperature may comprise: a polymer backbone comprising one or more side chains that comprise a heterocycle; and an amine-free polyether arm appended, via an alkyl spacer or a hydroxy-functionalized alkyl spacer, to the heterocycle of at least a portion of the one or more side chains.
    Type: Application
    Filed: June 11, 2019
    Publication date: January 6, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Balasubrahmanya S. BOMMAKANTI, John V. LATOUR, Udo HOSS, Tianmei OUYANG, Phu LE, Gary SANDHU, Kevin WALLIS
  • Publication number: 20210386334
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 26, 2021
    Publication date: December 16, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20210251530
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a sensing surface that includes an array two or more discontiguous sensing elements deposited on a substrate surface, where the sensing elements comprise one or more droplets of a sensing element formulation.
    Type: Application
    Filed: April 14, 2021
    Publication date: August 19, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Phu Le, Yi Wang, Frank David Fujimoto, Suyue Qian, Lam Tran
  • Publication number: 20210121106
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: November 9, 2020
    Publication date: April 29, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Patent number: 10827954
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: November 10, 2020
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le